U.S. pharma giant copyright scrapped two experimental weight loss supplements last yr—a the moment-daily pill, lotiglipron, due to elevated liver enzymes in addition to a 2 times-day by day tablet, danuglipron, resulting from potent Negative effects—but CEO Albert Bourla has reported the company is decided to “Participate in and gain” insid